Internal Medicine, Cardiovascular Disease · Miami, FL
NPI
1356304455
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
5
Medicare group memberships
Hospitals
5
Hospital affiliations
11160 SW 88th St, Suite 111
Miami, FL, 33176
Phone (305) 596-2325
Groups this clinician bills Medicare through
Medicare paid, 2024
$119K
1,945 services
Medicare patients, 2024
866
Average age 79
Drug cost, 2024
$4.0M
19,071 prescriptions
Company payments, 2025
$334
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Edgardo M Cespedes was code 93010 (electrocardiogram), 728 times for 569 patients. In total Edgardo M Cespedes billed 1,945 services in 38 codes, and Medicare paid $119K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-07-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93010 Electrocardiogram | Facility | 728 | 569 | $6.65 | $4,840 |
| 99214 Office E&M - Established | Office | 345 | 143 | $92.10 | $32K |
| 93000 Electrocardiogram | Office | 235 | 132 | $10.67 | $2,507 |
| 93306 Echocardiography (TTE/TEE) | Facility | 195 | 190 | $54.37 | $11K |
| 93306 Echocardiography (TTE/TEE) | Office | 61 | 60 | $130.66 | $7,970 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 45 | 45 | $143.80 | $6,471 |
| 93228 Electrocardiogram | Office | 44 | 42 | $20.10 | $884 |
| 93970 Duplex Scan - Extremity Veins | Office | 41 | 39 | $136.14 | $5,582 |
| 93925 Duplex Scan - Extremity Arteries | Office | 29 | 28 | $194.49 | $5,640 |
| 93978 Duplex Scan - Extremity Arteries | Office | 17 | 17 | $133.23 | $2,265 |
| 93015 Electrocardiogram | Office | 15 | 15 | $53.67 | $805 |
| 93224 Electrocardiogram | Office | 11 | 11 | $54.25 | $597 |
By year: 2022 $257K for 3,830 services; 2023 $163K for 2,379 services; 2024 $119K for 1,945 services.
Medicare prescription drug claims, 2024
In 2024, the drug Edgardo M Cespedes prescribed most often to Medicare patients was Rosuvastatin Calcium, with 1,165 prescriptions and refills. In total Edgardo M Cespedes wrote 19,071 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 1,165 | 2,941 | 320 | $12K |
| Clopidogrel Clopidogrel Bisulfate | 911 | 2,206 | 266 | $6,248 |
| Amlodipine Besylate Generic | 665 | 1,639 | 202 | $2,701 |
| Atorvastatin Calcium Generic | 607 | 1,572 | 178 | $4,653 |
| Famotidine Generic | 579 | 1,405 | 168 | $11K |
| Metoprolol Succinate Generic | 513 | 1,308 | 136 | $3,564 |
| Spironolactone Generic | 488 | 1,133 | 135 | $2,218 |
| Vascepa Icosapent Ethyl | 469 | 873 | 121 | $309K |
| Ezetimibe Generic | 464 | 1,192 | 152 | $6,685 |
| Carvedilol Generic | 438 | 1,022 | 119 | $2,453 |
| Folic Acid Generic | 399 | 1,072 | 130 | $2,716 |
| Pantoprazole Sodium Generic | 367 | 852 | 107 | $2,754 |
| Gabapentin Generic | 361 | 748 | 112 | $7,808 |
| Olmesartan Medoxomil Generic | 320 | 810 | 96 | $3,048 |
| Eliquis Apixaban | 307 | 638 | 88 | $374K |
Brand drugs: 3,281 claims; generic drugs: 15,754 claims; opioid claims: 27.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Edgardo M Cespedes $334 ($334 in general payments such as food, travel and fees) from 8 companies. The largest payer was Novo Nordisk Inc with $89.36.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 4 | $89.36 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $71.57 |
| Actelion Pharmaceuticals US, Inc. JNJ | 2 | $56.46 |
| GlaxoSmithKline, LLC. GSK | 1 | $26.25 |
| Corcept Therapeutics CORT | 1 | $24.48 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $23.59 |
| Exact Sciences Corporation EXAS | 1 | $22.08 |
| Baxter Healthcare BAX | 1 | $20.27 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.